Rosenberg SA - Search Results

1

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.

McCabe BJ, Irvine KR, Nishimura MI, Yang JC, Spiess PJ, Shulman EP, Rosenberg SA, Restifo NP. McCabe BJ, et al. Among authors: rosenberg sa. Cancer Res. 1995 Apr 15;55(8):1741-7. Cancer Res. 1995. PMID: 7536130 Free PMC article.

2

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Topalian SL, Sherry RM, Restifo NP, Wunderlich JR, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, Gritz L, Panicali DL, White DE. Rosenberg SA, et al. Clin Cancer Res. 2003 Aug 1;9(8):2973-80. Clin Cancer Res. 2003. PMID: 12912944 Free PMC article. Clinical Trial.

3

Bcl-2 overexpression enhances tumor-specific T-cell survival.

Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA. Charo J, et al. Among authors: rosenberg sa. Cancer Res. 2005 Mar 1;65(5):2001-8. doi: 10.1158/0008-5472.CAN-04-2006. Cancer Res. 2005. PMID: 15753400 Free PMC article.

4

Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.

Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA. Zhao Y, et al. Among authors: rosenberg sa. Cancer Res. 2007 Mar 15;67(6):2425-9. doi: 10.1158/0008-5472.CAN-06-3977. Cancer Res. 2007. PMID: 17363559 Free PMC article.

5

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer.

Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Shrimali RK, et al. Among authors: rosenberg sa. Cancer Res. 2010 Aug 1;70(15):6171-80. doi: 10.1158/0008-5472.CAN-10-0153. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631075 Free PMC article.

6

Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice.

Chinnasamy D, Tran E, Yu Z, Morgan RA, Restifo NP, Rosenberg SA. Chinnasamy D, et al. Among authors: rosenberg sa. Cancer Res. 2013 Jun 1;73(11):3371-80. doi: 10.1158/0008-5472.CAN-12-3913. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633494 Free PMC article.

7

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.

Cameron RB, Spiess PJ, Rosenberg SA. Cameron RB, et al. Among authors: rosenberg sa. J Exp Med. 1990 Jan 1;171(1):249-63. doi: 10.1084/jem.171.1.249. J Exp Med. 1990. PMID: 2295878 Free PMC article.

8

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes.

Rosenberg SA, Schwarz SL, Spiess PJ. Rosenberg SA, et al. J Natl Cancer Inst. 1988 Nov 2;80(17):1393-7. doi: 10.1093/jnci/80.17.1393. J Natl Cancer Inst. 1988. PMID: 3262772

9

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Spiess PJ, Yang JC, Rosenberg SA. Spiess PJ, et al. Among authors: rosenberg sa. J Natl Cancer Inst. 1987 Nov;79(5):1067-75. J Natl Cancer Inst. 1987. PMID: 3500355

10

Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.

Minev BR, McFarland BJ, Spiess PJ, Rosenberg SA, Restifo NP. Minev BR, et al. Among authors: rosenberg sa. Cancer Res. 1994 Aug 1;54(15):4155-61. Cancer Res. 1994. PMID: 7518351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters